ADJUPANRIX Trademark

Trademark Overview

On Wednesday, December 6, 2006, a trademark application was filed for ADJUPANRIX with the United States Patent and Trademark Office. The USPTO has given the ADJUPANRIX trademark a serial number of 77057787. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 29, 2015. This trademark is owned by GlaxoSmithKline Biologicals, S.A.. The ADJUPANRIX trademark is filed in the Pharmaceutical Products category with the following description:

vaccines for human use
adjupanrix

General Information

Serial Number77057787
Word MarkADJUPANRIX
Filing DateWednesday, December 6, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 29, 2015
Registration Number3523065
Registration DateTuesday, October 28, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 12, 2008

Trademark Statements

Goods and Servicesvaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 29, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Biologicals, S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals, S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals, S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events

Event DateEvent Description
Monday, June 8, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 29, 2015CANCELLED SEC. 8 (6-YR)
Friday, June 7, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 7, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 20, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 20, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 28, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, August 12, 2008PUBLISHED FOR OPPOSITION
Wednesday, July 23, 2008NOTICE OF PUBLICATION
Monday, July 7, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, July 5, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 19, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 19, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 18, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 14, 2008NOTIFICATION OF DISAPPROVAL - AMENDMENT TO USE E-MAILED
Monday, January 14, 2008DISAPPROVAL - AMENDMENT TO USE E-MAILED
Monday, January 14, 2008AMENDMENT OF ALLEGED USE DISAPPROVED
Monday, January 14, 2008SUSPENSION INQUIRY WRITTEN
Monday, January 14, 2008ASSIGNED TO LIE
Saturday, July 14, 2007NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, July 14, 2007LETTER OF SUSPENSION E-MAILED
Saturday, July 14, 2007SUSPENSION LETTER WRITTEN
Tuesday, July 10, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 10, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 10, 2007ASSIGNED TO LIE
Tuesday, June 26, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 18, 2007NON-FINAL ACTION E-MAILED
Thursday, January 18, 2007NON-FINAL ACTION WRITTEN
Saturday, January 13, 2007ASSIGNED TO EXAMINER
Monday, December 11, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

adjupanrix human vaccines